KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Equity (2016 - 2025)

Evolent Health has reported Return on Equity over the past 11 years, most recently at 0.85% for Q4 2025.

  • Quarterly results put Return on Equity at 0.85% for Q4 2025, down 79.0% from a year ago — trailing twelve months through Dec 2025 was 0.85% (down 79.0% YoY), and the annual figure for FY2025 was 0.75%, changed.
  • Return on Equity for Q4 2025 was 0.85% at Evolent Health, down from 0.15% in the prior quarter.
  • Over the last five years, Return on Equity for EVH hit a ceiling of 0.0% in Q4 2022 and a floor of 0.85% in Q4 2025.
  • Median Return on Equity over the past 5 years was 0.02% (2023), compared with a mean of 0.08%.
  • Biggest five-year swings in Return on Equity: skyrocketed 31bps in 2021 and later tumbled -79bps in 2025.
  • Evolent Health's Return on Equity stood at 0.01% in 2021, then skyrocketed by 95bps to 0.0% in 2022, then crashed by -3322bps to 0.02% in 2023, then plummeted by -227bps to 0.06% in 2024, then plummeted by -1306bps to 0.85% in 2025.
  • The last three reported values for Return on Equity were 0.85% (Q4 2025), 0.15% (Q3 2025), and 0.14% (Q2 2025) per Business Quant data.